MedSciences Capital http://www.medsciencescapital.com MedSciences Capital Fri, 07 Jun 2013 07:08:54 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Pronota is to receive patent on biomarker for diagnosting renal failure in the US despite Prometheus http://www.medsciencescapital.com/news/pronota-is-to-receive-patent-on-biomarker-for-diagnosting-renal-failure-in-the-us-despite-prometheus/ http://www.medsciencescapital.com/news/pronota-is-to-receive-patent-on-biomarker-for-diagnosting-renal-failure-in-the-us-despite-prometheus/#comments Thu, 06 Jun 2013 07:07:09 +0000 piet http://www.medsciencescapital.com/?p=1296 http://www.medsciencescapital.com/news/pronota-is-to-receive-patent-on-biomarker-for-diagnosting-renal-failure-in-the-us-despite-prometheus/feed/ 0 Prosensa Holding B.V. files Registration Statement for proposed Initial Public Offering http://www.medsciencescapital.com/news/prosensa-holding-b-v-files-registration-statement-for-proposed-initial-public-offering/ http://www.medsciencescapital.com/news/prosensa-holding-b-v-files-registration-statement-for-proposed-initial-public-offering/#comments Tue, 28 May 2013 09:15:45 +0000 piet http://www.medsciencescapital.com/?p=1290 http://www.medsciencescapital.com/news/prosensa-holding-b-v-files-registration-statement-for-proposed-initial-public-offering/feed/ 0 Better diagnosis of acute heart failure using Pronota’s novel biomarker http://www.medsciencescapital.com/news/better-diagnosis-of-acute-heart-failure-using-pronotas-novel-biomarker/ http://www.medsciencescapital.com/news/better-diagnosis-of-acute-heart-failure-using-pronotas-novel-biomarker/#comments Thu, 18 Apr 2013 10:26:05 +0000 piet http://www.medsciencescapital.com/?p=1283 http://www.medsciencescapital.com/news/better-diagnosis-of-acute-heart-failure-using-pronotas-novel-biomarker/feed/ 0 UMCG performs ‘test run’ on donor livers before transplantation http://www.medsciencescapital.com/news/umcg-performs-test-run-on-donor-livers-before-transplantation/ http://www.medsciencescapital.com/news/umcg-performs-test-run-on-donor-livers-before-transplantation/#comments Fri, 15 Mar 2013 13:35:05 +0000 piet http://www.medsciencescapital.com/?p=1275 http://www.medsciencescapital.com/news/umcg-performs-test-run-on-donor-livers-before-transplantation/feed/ 0 Prosensa Receives Rare Disease Company Award from EURORDIS http://www.medsciencescapital.com/news/prosensa-receives-rare-disease-company-award-from-eurordis/ http://www.medsciencescapital.com/news/prosensa-receives-rare-disease-company-award-from-eurordis/#comments Wed, 27 Feb 2013 09:45:50 +0000 piet http://www.medsciencescapital.com/?p=1272 http://www.medsciencescapital.com/news/prosensa-receives-rare-disease-company-award-from-eurordis/feed/ 0 Kiadis Pharma Receives Regulatory Approval from Health Canada for a Phase II Clinical Study with its Blood Cancer Treatment ATIR™ http://www.medsciencescapital.com/news/kiadis-pharma-receives-regulatory-approval-from-health-canada-for-a-phase-ii-clinical-study-with-its-blood-cancer-treatment-atir/ http://www.medsciencescapital.com/news/kiadis-pharma-receives-regulatory-approval-from-health-canada-for-a-phase-ii-clinical-study-with-its-blood-cancer-treatment-atir/#comments Tue, 26 Feb 2013 12:46:15 +0000 piet http://www.medsciencescapital.com/?p=1269 http://www.medsciencescapital.com/news/kiadis-pharma-receives-regulatory-approval-from-health-canada-for-a-phase-ii-clinical-study-with-its-blood-cancer-treatment-atir/feed/ 0 Larry Bell, MD Joins Prosensa as Head of Global Regulatory Affairs http://www.medsciencescapital.com/news/larry-bell-md-joins-prosensa-as-head-of-global-regulatory-affairs/ http://www.medsciencescapital.com/news/larry-bell-md-joins-prosensa-as-head-of-global-regulatory-affairs/#comments Thu, 07 Feb 2013 11:13:48 +0000 piet http://www.medsciencescapital.com/?p=1264 http://www.medsciencescapital.com/news/larry-bell-md-joins-prosensa-as-head-of-global-regulatory-affairs/feed/ 0 Prosensa Achieves Orphan Drug Status on its Entire Duchenne Muscular Dystrophy Portfolio http://www.medsciencescapital.com/news/prosensa-achieves-orphan-drug-status-on-its-entire-duchenne-muscular-dystrophy-portfolio/ http://www.medsciencescapital.com/news/prosensa-achieves-orphan-drug-status-on-its-entire-duchenne-muscular-dystrophy-portfolio/#comments Tue, 29 Jan 2013 13:13:07 +0000 piet http://www.medsciencescapital.com/?p=1262 http://www.medsciencescapital.com/news/prosensa-achieves-orphan-drug-status-on-its-entire-duchenne-muscular-dystrophy-portfolio/feed/ 0 Kiadis Pharma Granted U.S. Patent for its Blood Cancer Treatment ATIR™ http://www.medsciencescapital.com/news/kiadis-pharma-granted-u-s-patent-for-its-blood-cancer-treatment-atir/ http://www.medsciencescapital.com/news/kiadis-pharma-granted-u-s-patent-for-its-blood-cancer-treatment-atir/#comments Tue, 22 Jan 2013 13:16:29 +0000 piet http://www.medsciencescapital.com/?p=1258 http://www.medsciencescapital.com/news/kiadis-pharma-granted-u-s-patent-for-its-blood-cancer-treatment-atir/feed/ 0 Henri Termeer joins Prosensa as Strategic Advisor http://www.medsciencescapital.com/news/henri-termeer-joins-prosensa-as-strategic-advisor/ http://www.medsciencescapital.com/news/henri-termeer-joins-prosensa-as-strategic-advisor/#comments Thu, 13 Dec 2012 09:05:33 +0000 piet http://www.medsciencescapital.com/?p=1256 http://www.medsciencescapital.com/news/henri-termeer-joins-prosensa-as-strategic-advisor/feed/ 0